Concepedia

MH Brampton

MB

Statistics

Publications

5

Citations

693

H-Index

5

Active since

1995

Affiliations

Charing Cross Hospital(Current)

MH Brampton is an author at Charing Cross Hospital specializing in oncology, chemotherapy, and medicine.

Publications per year

1995–2002

5

Publications

5

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma

Mark Bower, E.S. Newlands, N M Bleehen et al. · Cancer Chemotherapy and Pharmacology · 1997 · 221 citations

, , +13

Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer.

D.J. Boote, Ian F. Dennis, P R Twentyman et al. · Journal of Clinical Oncology · 1996 · 176 citations

, , +17

The charing cross hospital experience with temozolomide in patients with gliomas

E.S. Newlands, S.M. O'Reilly, M.G. Glaser et al. · European Journal of Cancer · 1996 · 160 citations

, , +7

Effect of temozolomide on central nervous system relapse in patients with advanced melanoma

M. J. Paul, Yvonne Summers, A. Hilary Calvert et al. · Melanoma Research · 2002 · 104 citations

, , +13

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma

D. Crowther, PWM Johnson, M Soukop et al. · British Journal of Cancer · 1995 · 32 citations · Full text

, , +9

1–5 of 5